EXPRESSION OF THE SART3 TUMOR REJECTION ANTIGEN IN RENAL CELL CARCINOMA
β Scribed by KAWAGOE, NOBUTOSHI; SHINTAKU, ICHIRO; YUTANI, SHIGERU; ETOH, HIROSHI; MATUOKA, KEI; NODA, SHINSHI; ITOH, KYOGO
- Book ID
- 122935556
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2000
- Tongue
- English
- Weight
- 462 KB
- Volume
- 164
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We have reported a tumor-rejection antigen, SART1 259 , possessing tumor epitopes capable of inducing cytotoxic T lymphocytes (CTLs) in epithelial-cancer patients. This study investigated the expression of SART1 259 antigen in brain tumors, to explore for a potential molecule for use in specific imm
We investigated in breast cancers the expression of the SART-1 gene encoding tumor rejection antigens. SART-1 mRNA was expressed in all of the samples tested. The SART-1 800 antigen was detectable in 20 of 50 (40%) breast cancer tissues and all breast cancer cell lines tested, but not in normal brea
## Abstract ## BACKGROUND The authors recently reported that the SART2 and SART3 antigens encode tumor epitopes recognized by HLAβA24βrestricted and tumorβspecific cytotoxic T lymphocytes (CTLs) established from esophageal carcinoma patients. The current study investigated these antigens to explor